TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmaq Fishteq AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
4,799
|
4,643
|
4,941 |
| Financial expenses |
153
|
123
|
150 |
| Earnings before taxes |
777
|
-2,570
|
-350 |
| Total assets |
3,273
|
6,490
|
7,170 |
| Current assets |
1,983
|
4,821
|
2,920 |
| Current liabilities |
1,638
|
5,359
|
5,827 |
| Equity capital |
1,635
|
1,104
|
1,284 |
| - share capital |
8
|
8
|
9 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.0%
|
17.0%
|
17.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
16.2%
|
-55.4%
|
-7.1% |
| Return on assets (ROA) |
28.4%
|
-37.7%
|
-2.8% |
| Current ratio |
121.1%
|
90.0%
|
50.1% |
| Return on equity (ROE) |
47.5%
|
-232.8%
|
-27.3% |
| Change turnover |
450
|
-38
|
540 |
| Change turnover % |
10%
|
-1%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.